Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors

Annals of Surgical Oncology
Dana A OsborneLarry K Kvols

Abstract

Few data exist regarding outcomes after resection versus embolic treatment of symptomatic metastatic carcinoid and neuroendocrine tumors. The purpose of this study was to determine whether cytoreduction provides any benefit over embolic management of diffuse neuroendocrine tumors. A prospective database of 734 patients treated at our institution was retrospectively queried for symptomatic metastatic tumors treated with embolization or cytoreduction. Patients were compared with regard to pretreatment performance status, relief of symptoms, and survival. A total of 120 patients were identified: 59 undergoing embolization and 61 undergoing cytoreduction. Twenty-three patients had palliative cytoreduction (gross residual disease). Pretreatment performance status (Eastern Cooperative Oncology Group) was similar for both groups: .7+/-.70 (embolization) versus .8+/-.72 (cytoreduction; P=.27). Complete symptomatic relief was observed in 59% and partial relief in 32% of patients who underwent embolization, with a mean symptom-free interval of 22+/-13.6 months. A total of 69% of patients who underwent cytoreduction had complete symptomatic relief, and 23% had partial relief (P=.08 vs. embolization). The mean duration of relief was 35+/-2...Continue Reading

References

Jan 1, 1991·Digestion·H AhlmanL E Tisell
May 1, 1990·World Journal of Surgery·C MakridisG Akerström
Oct 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C G Moertel
Sep 1, 1970·Cancer·J H Foster
Jan 1, 1982·World Journal of Surgery·H GotoI Yokoyama
Apr 1, 1983·Annals of Surgery·H H ThompsonW P Longmire
Mar 1, 1983·Annals of Surgery·S IwatsukiT E Starzl
Apr 1, 1983·Archives of Surgery·W E StrodelN Thompson
Jan 1, 1995·American Journal of Surgery·F G QueL K Kvols
Nov 1, 1994·British Journal of Cancer·J N NewtonD J Reynolds
Feb 15, 1997·Cancer·I M Modlin, A Sandor
Jul 11, 1998·Journal of the American College of Surgeons·H ChenM A Choti
May 6, 1999·Journal of Vascular and Interventional Radiology : JVIR·K T BrownL H Blumgart
Apr 11, 2000·Journal of the American College of Surgeons·R S ChamberlainL H Blumgart
Nov 7, 2002·Hematology/oncology Clinics of North America·Douglas L Fraker, Michael Soulen
Jul 2, 2003·Journal of the American College of Surgeons·Juan M SarmientoFlorencia G Que
Jan 7, 2004·American Journal of Surgery·Robert SutcliffeNigel Heaton
Mar 13, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·G Q PhanJ L Cameron

❮ Previous
Next ❯

Citations

Feb 10, 2012·International Journal of Hepatology·Ser Yee LeeLondon L P J Ooi
Jun 13, 2014·European Journal of Endocrinology·Stefano PartelliMassimo Falconi
Aug 12, 2014·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·K Holzer
Sep 24, 2014·AJR. American Journal of Roentgenology·Kenneth J Kolbeck, Khashayar Farsad
Dec 12, 2012·International Journal of Hepatology·Mark A Lewis, Timothy J Hobday
Nov 29, 2011·International Journal of Hepatology·Mark A Lewis, Joleen Hubbard
Aug 14, 2012·Journal of Gastroenterology·Tetsuhide ItoRobert T Jensen
Feb 25, 2011·The Oncologist·Chandrajit P Raut, Matthew H Kulke
Nov 5, 2011·Gut·John K RamageUNKNOWN UK and Ireland Neuroendocrine Tumour Society
Jan 29, 2008·Current Treatment Options in Cardiovascular Medicine·Alain M BernheimPatricia A Pellikka
Jan 12, 2012·International Journal of Hepatology·Martin Vyleta, Douglas Coldwell
Feb 10, 2012·International Journal of Hepatology·Eric LeeUmut Sarpel
Apr 21, 2012·International Journal of Hepatology·Ron BasuroyJohn K Ramage
Jul 4, 2012·Annals of Surgical Oncology·Sébastien GaujouxYuman Fong
Mar 26, 2011·Current Treatment Options in Oncology·Jennifer A Chan, Matthew H Kulke
Aug 28, 2012·Targeted Oncology·Sébastien GaujouxJacques Belghiti
Mar 25, 2011·Cardiovascular and Interventional Radiology·Shantanu K GaurRichard Baum
Aug 19, 2011·Cardiovascular and Interventional Radiology·Philipp M PaprottkaTobias F Jakobs
Jul 3, 2007·Expert Opinion on Emerging Drugs·Jennifer A Chan, Matthew H Kulke
Feb 9, 2016·Iranian Journal of Cancer Prevention·Seyed Reza Mousavi, Mahsa Ahadi
Mar 19, 2014·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Mickaël LesurtelGraeme J Poston
Jul 29, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Andrea FrillingUrsula Plöckinger
Jul 20, 2010·The Surgical Clinics of North America·Srinevas K Reddy, Bryan M Clary
May 25, 2010·Seminars in Oncology·Javier Nazario, Sanjay Gupta
Aug 23, 2006·Journal of Vascular and Interventional Radiology : JVIR·David C MadoffJames C Yao
Oct 20, 2009·The Surgical Clinics of North America·Aarti MathurSteven K Libutti
Oct 20, 2009·The Surgical Clinics of North America·Janice L Pasieka
Feb 5, 2008·Mayo Clinic Proceedings·Alain M BernheimPatricia A Pellikka
Dec 9, 2008·Current Problems in Surgery·E Christopher Ellison, Jerome A Johnson
Dec 15, 2015·Asia-Pacific Journal of Clinical Oncology·Marinos PericleousChristos Toumpanakis
Dec 15, 2015·Journal of Surgical Oncology·Neal BhutianiCharles R Scoggins
Dec 11, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J BendelowG J Poston
Jun 15, 2007·Seminars in Oncology·Boris Kuvshinoff, Yuman Fong
May 15, 2007·Progress in Cardiovascular Diseases·Alain M BernheimPatricia A Pellikka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Surgical Oncology
Christine S LandryRobert C G Martin
Journal of the American College of Surgeons
R S ChamberlainL H Blumgart
© 2021 Meta ULC. All rights reserved